High blood viscosity may predict mortality in COVID-19 hospitalization

Blood viscosity calculated using the Walburn-Schneck model may serve as an effective prognostic tool in hospitalized patients with SARS-CoV-2 infection, according to data published in the Journal of the American College of Cardiology.
Researchers reported that high estimated blood viscosity in the arteries was associated with an approximately 60% increased risk for mortality among patients hospitalized with COVID-19.
“Estimated blood viscosity can be derived from routine laboratory tests that include the hematocrit and globulins — total protein minus albumin,” Robert S.

Blood viscosity calculated using the Walburn-Schneck model may serve as an effective prognostic tool in hospitalized patients with SARS-CoV-2 infection, according to data published in the Journal of the American College of Cardiology.
Researchers reported that high estimated blood viscosity in the arteries was associated with an approximately 60% increased risk for mortality among patients hospitalized with COVID-19.
“Estimated blood viscosity can be derived from routine laboratory tests that include the hematocrit and globulins — total protein minus albumin,” Robert S.